TickerFactsScreenerDevelopers

AXIM BIOTECHNOLOGIES, INC. (AXIM) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $02011: $23.1K2012: $19.1K2013: $1272014: $661.1K2015: $134.2K2016: $713.3K2017: $2.06M2018: $1.81M2019: $511.6K2020: $457.2K2021: $453.0K2022: $47.3K$47.3K
2010Cash & Equivalents (USD)2022
Fiscal YearCash & EquivalentsChange YoY
2022$47.3K-89.6%
2021$453.0K-0.9%
2020$457.2K-10.6%
2019$511.6K-71.7%
2018$1.81M-12.3%
2017$2.06M+188.5%
2016$713.3K+431.7%
2015$134.2K-79.7%
2014$661.1K+520473.2%
2013$127-99.3%
2012$19.1K-17.3%
2011$23.1K—
2010$0—